User profiles for Yi Lin

Yi Lin

- Verified email at mayo.edu - Cited by 34119

Yi Lin

- Verified email at nasa.gov - Cited by 27011

Model selection and estimation in regression with grouped variables

M Yuan, Y Lin - Journal of the Royal Statistical Society Series B …, 2006 - academic.oup.com
We consider the problem of selecting grouped variables (factors) for accurate prediction in
regression. Such a problem arises naturally in many practical situations with the multifactor …

Quantum-sized carbon dots for bright and colorful photoluminescence

YP Sun, B Zhou, Y Lin, W Wang… - Journal of the …, 2006 - ACS Publications
We report that nanoscale carbon particles (carbon dots) upon simple surface passivation are
strongly photoluminescent in both solution and the solid state. The luminescence emission …

[HTML][HTML] Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma

…, OO Oluwole, T Siddiqi, Y Lin… - … England Journal of …, 2017 - Mass Medical Soc
Background In a phase 1 trial, axicabtagene ciloleucel (axi-cel), an autologous anti-CD19
chimeric antigen receptor (CAR) T-cell therapy, showed efficacy in patients with refractory …

Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis

…, X Chen, Y Ao, T Fitzpatrick, P Li, Y Zhou, Y Lin… - Journal of Infection, 2020 - Elsevier
Objective To better inform efforts to treat and control the current outbreak with a comprehensive
characterization of COVID-19. Methods We searched PubMed, EMBASE, Web of Science…

[HTML][HTML] Idecabtagene vicleucel in relapsed and refractory multiple myeloma

…, J Berdeja, S Lonial, N Raje, Y Lin… - … England Journal of …, 2021 - Mass Medical Soc
Background Idecabtagene vicleucel (ide-cel, also called bb2121), a B-cell maturation
antigen–directed chimeric antigen receptor (CAR) T-cell therapy, has shown clinical activity with …

Map-reduce for machine learning on multicore

CT Chu, S Kim, YA Lin, YY Yu… - Advances in neural …, 2006 - proceedings.neurips.cc
We are at the beginning of the multicore era. Computers will have increasingly many cores (processors),
but there is still no good programming framework for these architectures, and …

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma …

…, M Akram, F Hossain, S Rizvi, F Fan, Y Lin… - The Lancet, 2021 - thelancet.com
Background CARTITUDE-1 aimed to assess the safety and clinical activity of ciltacabtagene
autoleucel (cilta-cel), a chimeric antigen receptor T-cell therapy with two B-cell maturation …

[HTML][HTML] A review of SARS-CoV-2 and the ongoing clinical trials

…, AA Yarmishyn, YY Lin, YH Luo, YT Lin… - International journal of …, 2020 - mdpi.com
The sudden outbreak of 2019 novel coronavirus (2019-nCoV, later named SARS-CoV-2) in
Wuhan, China, which rapidly grew into a global pandemic, marked the third introduction of a …

[HTML][HTML] Origins of circulating endothelial cells and endothelial outgrowth from blood

Y Lin, DJ Weisdorf, A Solovey… - The Journal of clinical …, 2000 - Am Soc Clin Investig
Normal adults have a small number of circulating endothelial cells (CEC) in peripheral blood,
and endothelial outgrowth has been observed from cultures of blood. In this study we seek …

Functionalized carbon nanotubes: properties and applications

YP Sun, K Fu, Y Lin, W Huang - Accounts of chemical research, 2002 - ACS Publications
Carbon nanotubes can be functionalized via amidation and esterification of the nanotube-bound
carboxylic acids. The solubility of these functionalized carbon nanotubes makes it …